Results 121 to 130 of about 333,388 (343)

Man with dyspnea [PDF]

open access: gold, 2020
Mark Favot, Luke Collins
openalex   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller   +8 more
wiley   +1 more source

Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire

open access: yesInternational Journal of COPD, 2018
Marc Beaumont,1,2 Francis Couturaud,3 Florence Jego,4 Romain Pichon,5 Catherine Le Ber,1 Loïc Péran,1 Christophe Rogé,6 David Renault,6 Swathi Narayan,7 Gregory Reychler8–10 1Pulmonary Rehabilitation Unit, Morlaix Hospital ...
Beaumont M   +9 more
doaj  

Dyspnea lusoria [PDF]

open access: yesPneumologie, 2009
S, Krüger   +4 more
openaire   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation

open access: yesInternational Journal of COPD, 2020
Silvia Uccelli,1 Laura Pini,1 Damiano Bottone,1 Piera Ranieri,2 Nicla Orzes,1 Claudio Tantucci1 1Respiratory Medicine Unit, Department of Experimental and Clinical Sciences, University of Brescia, Brescia, Italy; 2Department of Internal Medicine and ...
Uccelli S   +5 more
doaj  

Dyspnea

open access: yesPublic Health and Emergency, 2016
Abstract This chapter provides an overview of the prevalence, pathophysiology, assessment, and clinical management of dyspnea, also known as breathlessness. Written for the advanced practice registered nurse who cares for people with advanced disease, it describes the current understanding of the pathophysiology of dyspnea, potential ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy